Aβ凝集体の広域伝播とtau病態発症の分子機序の解明と早期治療法の開発

• Project/Area Number: 25K02471
• Research Category: Grant-in-Aid for Scientific Research (B)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 49010:Pathological biochemistry-related
• Research Institution: Foundation for Biomedical Research and Innovation at Kobe
• Principal Investigator: 星 美奈子 公益財団法人神戸医療産業都市推進機構, その他部局等, 研究員(副センター長・部長クラス) (30374010)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥18,720,000 (Direct Cost: ¥14,400,000、Indirect Cost: ¥4,320,000); Fiscal Year 2027: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000); Fiscal Year 2026: ¥6,890,000 (Direct Cost: ¥5,300,000、Indirect Cost: ¥1,590,000); Fiscal Year 2025: ¥7,150,000 (Direct Cost: ¥5,500,000、Indirect Cost: ¥1,650,000)